EMEA-001742-PIP02-16

Key facts

Active substance
Derivative of 4H-pyrazolo[3,4-d]pyrimidin-4-one
Therapeutic area
Psychiatry
Decision number
P/0338/2016
PIP number
EMEA-001742-PIP02-16
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Prevention of psychosis
Route(s) of administration
Oral use
Contact for public enquiries
Boehringer Ingelheim International
Germany
E-mail: paediatrics@boehringer-ingelheim.com
Tel.: +49 6132778271
Fax: 49 6132776601
Decision type
RP: decision refers to a refusal on a proposed Paediatric Investigation Plan

Decision

How useful was this page?

Add your rating